# A Study to Evaluate the Blood Levels, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants

> **NCT07700329** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Celgene** · enrollment: 16 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** BMS-986368
- **OTHER:** BMS-986368-matching Placebo

## Key facts

- **NCT ID:** NCT07700329
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-05
- **Primary completion:** 2027-02-23
- **Final completion:** 2027-02-23
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700329, "A Study to Evaluate the Blood Levels, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07700329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*